Knowledge Distillery

Ninety-six patients with severe COVID-19 who survived intensive care unit (ICU) admission were enrolled in this prospective longitudinal cohort study.…

Post-mortem studies have shown that patients dying from SARS-CoV-2 infection frequently have pathological changes in their CNS, particularly in the…

Messenger RNA (mRNA) vaccines provide robust protection against SARS-CoV-2 in healthy individuals. However, immunity after vaccination of patients…

The COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapies (DMT), particularly anti-CD20 monoclonal antibodies (mAb) and…

After acute coronavirus disease-2019 (COVID-19), people often experience fatigue, "brain fog," or other central neurologic symptoms (neuro-post-acute…

In 2024, the sequalae of the acute phase of coronavirus disease-19 (COVID-19) infection, which include neurological symptoms and are commonly referred…

Between 2.5% and 28% of people infected with SARS-CoV-2 suffer long COVID or persistence of symptoms for months after acute illness. Many symptoms are…

Previous reports and meta-analyses derived from small case series reported a mortality rate of up to 40% in patients with coronavirus disease 2019…

In October 2020, the European Academy of Neurology (EAN) consensus statement for management of patients with neurological diseases during the…

The authors studied blood-brain barrier (BBB) dysfunction in patients during acute SARS-Cov2 infection (76 inpatients and 25 pre-pandemic controls).…

This longitudinal study analysed digital cognitive tests’ data measuring executive functions (EF) and working memory (WM) from 3142 older adults (> 50…

Respiratory infection with SARS-CoV-2 causes systemic vascular inflammation and cognitive impairment. In this study the authors sought to identify the…